REIT - Healthcare Facilities
Compare Stocks
3 / 10Stock Comparison
CTRE vs SBRA vs LTC
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
CTRE vs SBRA vs LTC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities |
| Market Cap | $8.76B | $5.14B | $1.85B |
| Revenue (TTM) | $324M | $813M | $263M |
| Net Income (TTM) | $261M | $156M | $118M |
| Gross Margin | 96.6% | 63.5% | 79.4% |
| Operating Margin | 55.7% | 29.0% | 79.4% |
| Forward P/E | 26.5x | 29.5x | 19.7x |
| Total Debt | $0.00 | $2.55B | $644M |
| Cash & Equiv. | $198M | $72M | $14M |
CTRE vs SBRA vs LTC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| CareTrust REIT, Inc. (CTRE) | 100 | 211.2 | +111.2% |
| Sabra Health Care R… (SBRA) | 100 | 151.4 | +51.4% |
| LTC Properties, Inc. (LTC) | 100 | 103.8 | +3.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CTRE vs SBRA vs LTC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CTRE carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 108.7%, EPS growth 96.3%, 3Y rev CAGR 36.5%
- 272.9% 10Y total return vs SBRA's 54.1%
- PEG 1.25 vs LTC's 24.19
SBRA is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 0 yrs, beta -0.06, yield 5.8%
- Beta -0.06, yield 5.8%, current ratio 0.56x
LTC is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta -0.02, Low D/E 55.4%, current ratio 2.51x
- Lower P/E (19.7x vs 29.5x)
- Lower D/E ratio (55.4% vs 90.3%)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 108.7% FFO/revenue growth vs SBRA's 10.2% | |
| Value | Lower P/E (19.7x vs 29.5x) | |
| Quality / Margins | 80.6% margin vs SBRA's 19.2% | |
| Stability / Safety | Lower D/E ratio (55.4% vs 90.3%) | |
| Dividends | 3.2% yield, 2-year raise streak, vs SBRA's 5.8%, (1 stock pays no dividend) | |
| Momentum (1Y) | +40.9% vs LTC's +17.1% | |
| Efficiency (ROA) | 5.7% ROA vs SBRA's 2.8%, ROIC 8.9% vs 3.8% |
CTRE vs SBRA vs LTC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CTRE vs SBRA vs LTC — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CTRE leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SBRA is the larger business by revenue, generating $813M annually — 3.1x LTC's $263M. CTRE is the more profitable business, keeping 80.6% of every revenue dollar as net income compared to SBRA's 19.2%. On growth, CTRE holds the edge at +82.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $324M | $813M | $263M |
| EBITDAEarnings before interest/tax | $262M | $432M | $247M |
| Net IncomeAfter-tax profit | $261M | $156M | $118M |
| Free Cash FlowCash after capex | $334M | $367M | $98M |
| Gross MarginGross profit ÷ Revenue | +96.6% | +63.5% | +79.4% |
| Operating MarginEBIT ÷ Revenue | +55.7% | +29.0% | +79.4% |
| Net MarginNet income ÷ Revenue | +80.6% | +19.2% | +44.9% |
| FCF MarginFCF ÷ Revenue | +103.2% | +45.1% | +37.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +82.4% | +20.8% | +60.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +66.7% | -5.9% | +4.6% |
Valuation Metrics
LTC leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 15.2x trailing earnings, LTC trades at a 52% valuation discount to SBRA's 31.8x P/E. Adjusting for growth (PEG ratio), CTRE offers better value at 1.18x vs LTC's 24.19x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $8.8B | $5.1B | $1.9B |
| Enterprise ValueMkt cap + debt − cash | $8.6B | $7.6B | $2.5B |
| Trailing P/EPrice ÷ TTM EPS | 25.06x | 31.84x | 15.16x |
| Forward P/EPrice ÷ next-FY EPS est. | 26.46x | 29.54x | 19.67x |
| PEG RatioP/E ÷ EPS growth rate | 1.18x | — | 24.19x |
| EV / EBITDAEnterprise value multiple | 15.21x | 16.90x | 10.06x |
| Price / SalesMarket cap ÷ Revenue | 18.39x | 6.63x | 7.05x |
| Price / BookPrice ÷ Book value/share | 1.99x | 1.76x | 1.53x |
| Price / FCFMarket cap ÷ FCF | 22.24x | 14.74x | 13.62x |
Profitability & Efficiency
LTC leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
LTC delivers a 10.1% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $6 for SBRA. LTC carries lower financial leverage with a 0.55x debt-to-equity ratio, signaling a more conservative balance sheet compared to SBRA's 0.90x. On the Piotroski fundamental quality scale (0–9), LTC scores 7/9 vs SBRA's 5/9, reflecting strong financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +6.5% | +5.6% | +10.1% |
| ROA (TTM)Return on assets | +5.1% | +2.8% | +5.7% |
| ROICReturn on invested capital | +10.1% | +3.8% | +8.9% |
| ROCEReturn on capital employed | +11.0% | +5.2% | +13.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 7 |
| Debt / EquityFinancial leverage | — | 0.90x | 0.55x |
| Net DebtTotal debt minus cash | -$198M | $2.5B | $630M |
| Cash & Equiv.Liquid assets | $198M | $72M | $14M |
| Total DebtShort + long-term debt | $0 | $2.6B | $644M |
| Interest CoverageEBIT ÷ Interest expense | 10.76x | 2.40x | 5.91x |
Total Returns (Dividends Reinvested)
CTRE leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CTRE five years ago would be worth $20,154 today (with dividends reinvested), compared to $12,351 for LTC. Over the past 12 months, CTRE leads with a +40.9% total return vs LTC's +17.1%. The 3-year compound annual growth rate (CAGR) favors CTRE at 30.0% vs LTC's 10.4% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +9.4% | +8.0% | +12.4% |
| 1-Year ReturnPast 12 months | +40.9% | +24.9% | +17.1% |
| 3-Year ReturnCumulative with dividends | +119.5% | +112.4% | +34.5% |
| 5-Year ReturnCumulative with dividends | +101.5% | +53.4% | +23.5% |
| 10-Year ReturnCumulative with dividends | +272.9% | +54.1% | +26.7% |
| CAGR (3Y)Annualised 3-year return | +30.0% | +28.5% | +10.4% |
Risk & Volatility
SBRA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SBRA is the less volatile stock with a -0.06 beta — it tends to amplify market swings less than CTRE's 0.14 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SBRA currently trades 96.7% from its 52-week high vs LTC's 93.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.14x | -0.06x | -0.02x |
| 52-Week HighHighest price in past year | $41.72 | $21.07 | $40.80 |
| 52-Week LowLowest price in past year | $27.72 | $17.04 | $33.64 |
| % of 52W HighCurrent price vs 52-week peak | +94.3% | +96.7% | +93.6% |
| RSI (14)Momentum oscillator 0–100 | 54.7 | 54.0 | 47.1 |
| Avg Volume (50D)Average daily shares traded | 2.5M | 2.1M | 355K |
Analyst Outlook
Evenly matched — CTRE and SBRA each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CTRE as "Buy", SBRA as "Hold", LTC as "Hold". Consensus price targets imply 8.0% upside for CTRE (target: $43) vs -5.8% for LTC (target: $36). For income investors, SBRA offers the higher dividend yield at 5.81% vs CTRE's 3.23%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $42.50 | $21.20 | $36.00 |
| # AnalystsCovering analysts | 19 | 29 | 22 |
| Dividend YieldAnnual dividend ÷ price | +3.2% | +5.8% | — |
| Dividend StreakConsecutive years of raises | 2 | 0 | 0 |
| Dividend / ShareAnnual DPS | $1.27 | $1.18 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% |
CTRE leads in 2 of 6 categories (Income & Cash Flow, Total Returns). LTC leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.
CTRE vs SBRA vs LTC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CTRE or SBRA or LTC a better buy right now?
For growth investors, CareTrust REIT, Inc.
(CTRE) is the stronger pick with 108. 7% revenue growth year-over-year, versus 10. 2% for Sabra Health Care REIT, Inc. (SBRA). LTC Properties, Inc. (LTC) offers the better valuation at 15. 2x trailing P/E (19. 7x forward), making it the more compelling value choice. Analysts rate CareTrust REIT, Inc. (CTRE) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CTRE or SBRA or LTC?
On trailing P/E, LTC Properties, Inc.
(LTC) is the cheapest at 15. 2x versus Sabra Health Care REIT, Inc. at 31. 8x. On forward P/E, LTC Properties, Inc. is actually cheaper at 19. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CareTrust REIT, Inc. wins at 1. 25x versus LTC Properties, Inc. 's 24. 19x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — CTRE or SBRA or LTC?
Over the past 5 years, CareTrust REIT, Inc.
(CTRE) delivered a total return of +101. 5%, compared to +23. 5% for LTC Properties, Inc. (LTC). Over 10 years, the gap is even starker: CTRE returned +272. 9% versus LTC's +26. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CTRE or SBRA or LTC?
By beta (market sensitivity over 5 years), Sabra Health Care REIT, Inc.
(SBRA) is the lower-risk stock at -0. 06β versus CareTrust REIT, Inc. 's 0. 14β — meaning CTRE is approximately -311% more volatile than SBRA relative to the S&P 500. On balance sheet safety, LTC Properties, Inc. (LTC) carries a lower debt/equity ratio of 55% versus 90% for Sabra Health Care REIT, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CTRE or SBRA or LTC?
By revenue growth (latest reported year), CareTrust REIT, Inc.
(CTRE) is pulling ahead at 108. 7% versus 10. 2% for Sabra Health Care REIT, Inc. (SBRA). On earnings-per-share growth, the picture is similar: CareTrust REIT, Inc. grew EPS 96. 3% year-over-year, compared to 18. 5% for Sabra Health Care REIT, Inc.. Over a 3-year CAGR, CTRE leads at 36. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CTRE or SBRA or LTC?
CareTrust REIT, Inc.
(CTRE) is the more profitable company, earning 67. 3% net margin versus 20. 1% for Sabra Health Care REIT, Inc. — meaning it keeps 67. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTRE leads at 98. 7% versus 34. 1% for SBRA. At the gross margin level — before operating expenses — CTRE leads at 98. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CTRE or SBRA or LTC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, CareTrust REIT, Inc. (CTRE) is the more undervalued stock at a PEG of 1. 25x versus LTC Properties, Inc. 's 24. 19x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, LTC Properties, Inc. (LTC) trades at 19. 7x forward P/E versus 29. 5x for Sabra Health Care REIT, Inc. — 9. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CTRE: 8. 0% to $42. 50.
08Which pays a better dividend — CTRE or SBRA or LTC?
In this comparison, SBRA (5.
8% yield), CTRE (3. 2% yield) pay a dividend. LTC does not pay a meaningful dividend and should not be held primarily for income.
09Is CTRE or SBRA or LTC better for a retirement portfolio?
For long-horizon retirement investors, Sabra Health Care REIT, Inc.
(SBRA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 06), 5. 8% yield). Both have compounded well over 10 years (SBRA: +54. 1%, LTC: +26. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CTRE and SBRA and LTC?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CTRE is a small-cap high-growth stock; SBRA is a small-cap income-oriented stock; LTC is a small-cap high-growth stock. CTRE, SBRA pay a dividend while LTC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.